Acta Med. 2001, 44: 37-39
https://doi.org/10.14712/18059694.2019.85
Determination of Serum B12 Vitamin and Folic Acid Levels in Patient with Stroke
References
1. ML, Launer LJ, Lindemans J et al. Homocysteine and short-term risk of myocardial infarction and stroke in the elderly. Arch Intern Med 1999; 159(1):38-44.
<https://doi.org/10.1001/archinte.159.1.38>
2. L, Lindgren A, Israelsson B et al. Hyperhomocysteinaemia in stroke: prevalence, cause and relationships to type of stroke and stroke risk factors. Eur J Clin Invest 1992; 22(3):214-21.
<https://doi.org/10.1111/j.1365-2362.1992.tb01829.x>
3. BM, Malinow MR, Beamer N, Sexton G, Nordt F, de Garmo P. Elevated plasma homocyst(e)ine concentration as a possible risk for stroke. Stroke 1990; 21(4):572-6.
<https://doi.org/10.1161/01.STR.21.4.572>
4. R, Ubbink JB, Vermaak WJ, Rossouw H, Becker PJ, Joubert J. Hyperhomocysteinaemia in black patients with cerebral thrombosis. QJM 1997; 90(10): 635-9.
<https://doi.org/10.1093/qjmed/90.10.635>
5. J, Kroesen M, Pietrzik K. Folic acid and vitamin B6 supplementation and plasma homocysteine concentration in healthy young women. Int J Vitam Nutr Res 1998; 68(2):98-103.
6. P, Prost M, Blache D. Folate Deficiencies and cardiovasculer pathologies. Clin Chem Lab Med 1998; 36(7):419-29.
<https://doi.org/10.1515/CCLM.1998.072>
7. B, Andersson A, Lindgren A. Marginal folate deficiency as a possible cause of hyperhomocysteinaemia in stroke patients. Eur J Chem Clin Biochem 1997; 35(1):25-8.
8. WH, Croft JB, Greenlund KJ, Ford ES, Kittner SJ. Total homocyst(e)ine concentration and the likelihood of nonfatal stroke: results from the Third National Health and Nutrition Examination Survey, 1988-1994. Stroke 1998; 29(12):2473-7.
<https://doi.org/10.1161/01.STR.29.12.2473>
9. IM, Daly LE, Refsum HM et al. Plasma homocysteine as a risk factor for vascular disease. The european concerted project. JAMA 1997; 277(22):1775-81.
<https://doi.org/10.1001/jama.1997.03540460039030>
10. M, Kaya H, Keleş S, Türker H, Tekin B, Akarsu E. Yaşlı hastalarda B12 ve folik asit eksikliği. Türkiye Tıp Dergisi 1998; 5(3):153-6.
11. W, Aull S, Korninger L et al. 677C to T mutation in the 5,10-methylenetetrahydrofolate reductase (MTHFR) gene and plasma homocyst(e)ine levels in patients with TIA or minor stroke. J Neurol Sci 1998; 155(2):156-62.
<https://doi.org/10.1016/S0022-510X(97)00311-0>
12. MR. Plasma homocyst(e)ine and arterial occlusive diseases: a mini review. Clin Chem 1995; 41(1):173-6.
13. L, Bottiglieri T, Lowenthal D. Role of homocysteine in age-related vascular and non-vascular diseases. Aging(Milano) 1997; 9(4):241-57.
14. K, Bronstrup A. The role of homocysteine, folate and other B-vitamins in the development of atherosclerosis. Arch Latinoamer Nutr 1997; 47(2) Supp.1: 9-12.
15. K, Arheart K, Refsum H et al. Low curcilating folate and vitamin B6 concentrations: risk factors for stroke, pheripheral vascular disease and coronary artery disease. Circulation 1998; 97(5):437-43.
<https://doi.org/10.1161/01.CIR.97.5.437>
16. P, Stampfer MJ, Buring JE et al. Homocysteine metabolism and risk of myocardial infarction:relation with vitamins B6, B12 and folate. Am J Epidemiol 1996; 143(9):845-59.
<https://doi.org/10.1093/oxfordjournals.aje.a008828>
17. N, Deulofeu R, Chamorro A, Piera C. Plasma homocysteine levels in patients with ischemic cerebral infarction. Med Clin (Barc) 1998; 110(16):605-8.
18. JH, Chung CS, Kang SS. Relation of plasma homocyst(e)ine to cerebral infarction and cerebral atherosclerosis. Stroke 1998; 29(12):2478-83.
<https://doi.org/10.1161/01.STR.29.12.2478>
